We are live on ! Find out more
PRQR icon

ProQR Therapeutics

51 hedge funds and large institutions have $299M invested in ProQR Therapeutics in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more capital invested

Capital invested by funds: $125M → $299M (+$174M)

133% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 9

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

47% more call options, than puts

Call options by funds: $22K | Put options by funds: $15K

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

5.34% more ownership

Funds ownership: 55.73%61.07% (+5.3%)

2% more funds holding

Funds holding: 5051 (+1)

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
21
Reduced
9
Closed
15
Calls
$22K
Puts
$15K
Net Calls
+$7K
Net Calls Change
+$7K
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$494K +$388K +49,800 New
Arrowstreet Capital
27
Arrowstreet Capital
Massachusetts
$426K +$335K +42,947 New
BFM
28
Boothbay Fund Management
New York
$357K +$281K +36,051 New
Group One Trading
29
Group One Trading
Illinois
$316K +$185K +23,784 +293%
PP
30
Paloma Partners
Connecticut
$199K +$156K +20,078 New
AAP
31
Ardsley Advisory Partners
Connecticut
$198K +$156K +20,000 New
Two Sigma Investments
32
Two Sigma Investments
New York
$182K -$19.4K -2,493 -12%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$166K +$130K +16,748 New
EMG
34
Ellington Management Group
Connecticut
$151K +$118K +15,200 New
Mirae Asset Global Investments
35
Mirae Asset Global Investments
South Korea
$140K +$110K +14,087 New
Wells Fargo
36
Wells Fargo
California
$119K +$7.79K +1,000 +9%
State Street
37
State Street
Massachusetts
$117K -$873K -112,046 -90%
Walleye Capital
38
Walleye Capital
New York
$113K +$88.7K +11,393 New
ProShare Advisors
39
ProShare Advisors
Maryland
$106K +$1.07K +138 +1%
TRCT
40
Tower Research Capital (TRC)
New York
$40K +$31.7K +4,073 New
Citigroup
41
Citigroup
New York
$38K +$21.8K +2,805 +274%
Deutsche Bank
42
Deutsche Bank
Germany
$36K -$267K -34,338 -90%
Morgan Stanley
43
Morgan Stanley
New York
$17K -$5.49K -705 -30%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$17K +$7.76K +996 +133%
LC
45
Lindbrook Capital
California
$14K +$6.23K +800 +133%
ClearBridge Investments
46
ClearBridge Investments
New York
$10K
Barclays
47
Barclays
United Kingdom
$4K -$15.1K -1,937 -85%
Daiwa Securities Group
48
Daiwa Securities Group
Japan
$2K
PA
49
Parallel Advisors
California
$2K +$1.75K +225 New
Bank of America
50
Bank of America
North Carolina
$2K +$1.81K +232 New

PRQR Hedge Fund Activity: Q4 2019 in Review

51 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2019, worth a combined $299M — up 139% from $125M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PRQR positions and 15 closed out — a net gain of 2 holders — while 21 added to existing stakes and 9 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $37.3M. The largest seller was BlackRock, cutting an estimated $2.59M.

  • 51 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2019, up from 50 in Q3 2019.
  • Funds reported $299M of ProQR Therapeutics stock for Q4 2019, up 139% quarter-over-quarter.
  • 17 funds opened new ProQR Therapeutics positions in Q4 2019 and 15 closed out, a net change of +2 holders.
  • The largest ProQR Therapeutics buyer in Q4 2019 was Wellington Management Group, an estimated $37.3M added.
  • The largest ProQR Therapeutics seller in Q4 2019 was BlackRock, an estimated $2.59M sold.

Based on aggregated 13F filings for Q4 2019.